State health departments are exploring and testing new and innovative approaches that will provide critical insight and lessons learned. The aims of EFSD are to encourage and support research in the field of diabetes, to rapidly diffuse acquired knowledge and to facilitate its application. Helmsley Charitable Trust. Frequent episodes of problematic hypos occurring without symptoms. Merck Sharpe & Dohme, or MSD, is the name Merck uses for conducting its business in all other countries outside the United States and Canada. Please explore the numerous professional and general diabetes resources on this website to learn more about diabetes and this program; they are located in the right-hand column under the sections titled Resources and Publications. A study proposed by an early-stage investigator with a research interest in diabetes or obesity prior to securing independent grant support.
Support $25 million for the National Diabetes Prevention Program. Reducing health inequalities and inequities in the prevention and treatment of type 2 diabetes in both a local and global context. Together with its collaborators, the foundation has committed close to €100m to diabetes research in Europe by various funding means. Dr Craig Beall says: “No matter how much people know about diabetes or how careful they are, if diabetes is treated with certain medication such as insulin, you are likely to experience some hypos. Development of a dual-function glucose sensing and hormone delivery catheter for use within an artificial pancreas (multiple indicating electrode sensing catheter). As a part of the Thomson Reuters research analytics suite of solutions, ScienceWatch highlights the important role research evaluation and management play in supporting strategic decision making. In this new JDRF-funded research program, led by Jeffrey I.
EFSD may, on advisement from the Review Committee, recommend an award in a different amount than requested but which is considered more appropriate for the proposed studies. Studies forming part of a larger project will be considered for funding but this will need to be well justified in the application (see Review Considerations). There is no support for PI salary or indirect costs so they should not be included in the budget. The project must involve active collaboration with an identified partner working in Europe or one of its associated countries, with the proviso that at least 80% of the budget must be attributed to the principal investigator’s institution. Funding may be requested for any aspect of the clinical research described in the application, including for example the principal investigator’s salary and cost of travel between two collaborating centres.Contribution towards costs of research in the European partner centre may not exceed 20% of the total budget. A key hallmark of type 2 diabetes is insulin resistance. Research will be supported through the award of grants, each of up to Euro 100,000 in total for projects lasting up to 2 years.
Grants will be paid in the first year and in one instalment. I had to ask to be invited to this meeting.. Applicants who have a funding requirement larger than that specified above are also invited to apply to this Programme; in this case, the relevant financial requirements should be indicated and justified in the budget section of the application form. Research will be supported through the award of grants, each of up to to Euro 400,000 in total for projects lasting up to 3 years. This condition is called insulin resistance and it is reversible, especially if treated in the early stages. EFSD may, at the suggestion of the Review Committee, may at its discretion recommend an award in a different amount from that requested, but which is considered more appropriate for the proposed studies. The Albert Renold Travel Fellowships for Young Scientists enable young scientists to travel and stay at other institutions in order to learn different scientific techniques related to diabetes research.
Either the home or the host institution must be based in Europe or an associated country. The duration of the stay cannot exceed 3 months. Our staff and volunteers in more than 100 locations throughout the United States and our six international affiliates are dedicated to advocacy, community engagement and our vision of a world without T1D. The EFSD Albert Renold Fellowship Programme is supported by an unrestricted educational grant from Merck Sharp & Dohme (MSD).